News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,900 Results
Type
Article (86541)
Company Profile (702)
Press Release (760657)
Multimedia
Podcasts (132)
Webinars (14)
Section
Business (232708)
Career Advice (4128)
Deals (39725)
Drug Delivery (129)
Drug Development (90994)
Employer Resources (198)
FDA (18114)
Job Trends (17341)
News (396509)
Policy (39757)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56847)
ALS (107)
Alzheimer's disease (1510)
Antibody-drug conjugate (ADC) (165)
Approvals (18071)
Artificial intelligence (340)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (87)
Brain cancer (32)
Breast cancer (318)
Cancer (2517)
Cardiovascular disease (212)
Career advice (3535)
Career pathing (34)
CAR-T (182)
Cell therapy (512)
Cervical cancer (22)
Clinical research (73533)
Collaboration (946)
Company closure (2)
Compensation (593)
Complete response letters (30)
COVID-19 (2869)
CRISPR (50)
C-suite (279)
Cystic fibrosis (110)
Data (2422)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (305)
Diagnostics (6937)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (156)
Drug pricing (136)
Drug shortages (33)
Duchenne muscular dystrophy (107)
Earnings (97234)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130366)
Executive appointments (799)
FDA (19582)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (848)
Gene editing (125)
Generative AI (36)
Gene therapy (379)
GLP-1 (869)
Government (5179)
Grass and pollen (6)
Guidances (169)
Healthcare (20894)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (157)
Indications (30)
Infectious disease (3034)
Inflammatory bowel disease (159)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (104)
Interviews (813)
IPO (17841)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10116)
Liver cancer (82)
Lung cancer (352)
Lymphoma (164)
Machine learning (9)
Management (65)
Manufacturing (381)
MASH (87)
Medical device (14651)
Medtech (14656)
Mergers & acquisitions (22466)
Metabolic disorders (822)
Multiple sclerosis (90)
NASH (23)
Neurodegenerative disease (121)
Neuropsychiatric disorders (35)
Neuroscience (2147)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (438)
Opinion (276)
Ovarian cancer (84)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (167)
Partnered (25)
Patents (264)
Patient recruitment (120)
Peanut (51)
People (65369)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22699)
Phase II (31933)
Phase III (24044)
Pipeline (1486)
Policy (183)
Postmarket research (3552)
Preclinical (10248)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (271)
Rare diseases (441)
Real estate (7392)
Recruiting (75)
Regulatory (26852)
Reports (59)
Research institute (2659)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (6)
RSV (50)
Schizophrenia (84)
Series A (147)
Series B (98)
Service/supplier (30)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (58)
The Weekly (84)
Vaccines (827)
Venture capitalists (45)
Weight loss (308)
Women's health (41)
Worklife (20)
Date
Today (259)
Last 7 days (1016)
Last 30 days (3613)
Last 365 days (35526)
2025 (13439)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (61)
Alaska (7)
Arizona (271)
Arkansas (14)
Asia (50188)
Australia (8841)
California (6841)
Canada (2131)
China (583)
Colorado (296)
Connecticut (312)
Delaware (171)
Europe (115201)
Florida (997)
Georgia (232)
Hawaii (1)
Idaho (64)
Illinois (649)
India (31)
Indiana (348)
Iowa (12)
Japan (183)
Kansas (113)
Kentucky (28)
Louisiana (15)
Maine (71)
Maryland (1003)
Massachusetts (5217)
Michigan (256)
Minnesota (439)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (26)
Nevada (70)
New Hampshire (70)
New Jersey (1906)
New Mexico (31)
New York (1914)
North Carolina (1160)
North Dakota (9)
Northern California (2959)
Ohio (227)
Oklahoma (15)
Oregon (48)
Pennsylvania (1488)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (28)
South Dakota (1)
Southern California (2532)
Tennessee (110)
Texas (1025)
United States (26011)
Utah (199)
Virginia (180)
Washington D.C. (72)
Washington State (625)
West Virginia (3)
Wisconsin (74)
There are 847,900 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights
May 14, 2025
·
10 min read
Press Releases
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
·
8 min read
Press Releases
Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements
May 14, 2025
·
18 min read
Press Releases
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
11 min read
Press Releases
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th
May 14, 2025
·
2 min read
Press Releases
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
May 14, 2025
·
7 min read
Press Releases
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 14, 2025
·
16 min read
Press Releases
Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine
May 14, 2025
·
9 min read
Press Releases
BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
8 min read
Press Releases
Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia
May 14, 2025
·
8 min read
1 of 84,790
Next
